References
- Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol. 1980;5:195–211.
- Homma A, Oridate N, Suzuki F, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer. 2009;115:4705–4714.
- Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? JCO. 2006;24:2653–2658.
- Ohizumi Y, Tamai Y, Imamiya S, et al. Complications following re-irradiation for head and neck cancer. Am J Otolaryngol. 2002;23:215–221.
- Nieder C, Langendijk JA, Guckenberger M, et al. Prospective randomized clinical studies involving reirradiation: Lessons learned. Strahlenther Onkol. 2016;192:679–686.
- Baliga S, Kabarriti R, Ohri N, et al. Stereotactic body radiotherapy for recurrent head and neck cancer: a critical review. Head Neck. 2017;39:595–601.
- Lee N, Chan K, Bekelman JE, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:731–740.
- Yamazaki H, Demizu Y, Okimoto T, et al. Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy. Strahlenther Onkol. 2017;193:525–533.
- McDonald MW, Zolali-Meybodi O, Lehnert SJ, et al. Reirradiation of recurrent and second primary head and neck cancer with proton therapy. Int J Radiat Oncol Biol Phys. 2016;96:808–819.
- Riaz N, Hong JC, Sherman EJ, et al. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol. 2014;111:382–387.
- Brierley JD, Gospodarowicz MK, Wittekind D. TNM classification of malignant tumours. 8th ed. New York (NY): Wiley-Blackwell; 2016.
- Doi H, Oh RJ, Miura H, et al. Outcomes and toxicity of radiotherapy for refractory bone and soft tissue sarcomas. Mol Clin Oncol. 2016;4:83–88.
- Yamazaki H, Ogita M, Himei K, et al. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: a multiinstitutional matched-cohort analysis. Radiother Oncol. 2015;115:67–71.
- Janssen S, Baumgartner M, Bremer M, et al. Re-irradiation of head and neck cancer-impact of total dose on outcome. Anticancer Res. 2010;30:3781–3786.
- Choe KS, Haraf DJ, Solanki A, et al. Prior chemoradio- therapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer. 2011;117:4671–4678.
- Peitzsch C, Tyutyunnykova A, Pantel K, et al. Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10–24.
- Yu VY, Nguyen D, Pajonk F, et al. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance. Int J Radiat Oncol Biol Phys. 2015;91:866–875.
- Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23:457–467.